Description de l'entreprise
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Conseil d'administration & Conseil de surveillance
| PDG |
| Dr. Wolfgang Wienand |
| Conseil d'administration |
| Dr. Reto Suter, Dr. Jürgen Roos, Irene Wosgien, Marcel Imwinkelried, Marianne Späne, Henrik Krüpper, Christian Dowdeswell |
| Conseil de surveillance |
| Dr. Andreas Casutt, Alexandra Brand, Beat Walti, Dr. Martin Schmid, Isabelle Welton, Wolfram Carius, Elodie Carr-Cingari |
Données de l'entreprise
| Nom: |
Siegfried Holding AG |
| Adresse: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Téléphone: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| Courriel: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Industrie: |
Commodities |
| Secteur: |
Chemicals |
| Sous-secteur: |
- |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
75.10% |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Reto Suter |
| Téléphone IR: |
+41-62-746-15-35 |
| IR-Fax: |
- |
| E-mail IR: |
reto.suter@siegfried.ch
|
